Home›Search›Advances in Biomarker Sciences and Technology

Advances in Biomarker Sciences and Technology

KeAi Communications Co. Ltd. · China

eISSN2543-1064

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.335

H-Indexi

Aims & Scope

Subject areas: Public aspects of medicine: Toxicology. Poisons; Chemical technology: Biotechnology; Biology (General). Topics: molecular epidemiology, toxicology, biomarkers and technology, clinic diagonsis and treatment

General Information

Country / RegionChina

Primary LanguageEnglish

1st Year Published—

StatusActive

Total Publications—

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

Peer ReviewAnonymous peer review

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/11 · 73%

✅

Do you know the journal / publisher?

KeAi Communications Co. Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2543-1064

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Biochemistry (medical)Q3

Clinical BiochemistryQ4

Molecular MedicineQ4

Subject Classification

Research Topics (OpenAlex)

MicroRNA in disease regulationGut microbiota and healthEssential Oils and Antimicrobial ActivityCancer-related molecular mechanisms researchCOVID-19 Clinical Research StudiesComputational Drug Discovery MethodsLiver Disease Diagnosis and TreatmentMetabolomics and Mass Spectrometry StudiesArtificial Intelligence in HealthcareBrain Tumor Detection and Classification

Frequently asked questions about Advances in Biomarker Sciences and Technology

Is Advances in Biomarker Sciences and Technology a predatory journal?

PubScope has no integrity flags on record for Advances in Biomarker Sciences and Technology: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Advances in Biomarker Sciences and Technology?

Advances in Biomarker Sciences and Technology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.335.

Is Advances in Biomarker Sciences and Technology indexed in Scopus and Web of Science?

Advances in Biomarker Sciences and Technology is indexed in Scopus, DOAJ.